rituximab
not tagged
['lymsm']
side comment during q&amp;a: although study not powered to look at induction pmbcl regimens, rchop-21 clearly inferior. #lymsm #17icml
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈